| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH |
From the Department of Radiology, Georgetown University Hospital, Washington, DC; and MEDTAP International, Bethesda, Maryland.
Address reprint requests to: James B. Spies, MD, Department of Radiology, Georgetown University Hospital, CG 201, 3800 Reservoir Road, NW, Washington, DC 20007-2197; E-mail: spiesj{at}gunet.georgetown.edu.
OBJECTIVE: To create and validate a questionnaire for assessing symptom severity and symptom impact on health-related quality of life for women with leiomyomata.
METHODS: The questionnaire was derived from focus groups of women with leiomyomata. Content validity was established through cognitive debriefings of women with leiomyomata and review by expert clinicians. Patients for the validation study were recruited from five gynecologists’ offices, an interventional radiology department, and a University campus. Instruments used for validation were the Short Form-36, Menorrhagia Questionnaire, the Revicki-Wu Sexual Function Scale, and a physician and a patient assessment of severity. Item and exploratory factor analysis were performed to assess the subscale structure of the questionnaire. Psychometric evaluation was conducted to assess reliability and validity. Test-retest was performed on a random subset of the sample within 2 weeks of the initial visit.
RESULTS: A total of 110 patients with confirmed leiomyomata and 29 normal subjects participated in the validation. The final questionnaire consists of eight symptom questions and 29 health-related quality of life questions with six subscales. Subscale Cronbach’s 
ranged from 0.83 to 0.95, with the overall health-related quality of life score = 0.97. The Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire subscales discriminated not only from normal controls but also among leiomyomata patients with varying degrees of symptom severity. Test-retest reliability was good with intraclass correlation coefficients of 0.76–0.93.
CONCLUSION: The UFS-QOL appears to be a useful new tool for detecting differences in symptom severity and health-related quality of life among patients with uterine leiomyomata. Additional study is underway to determine the responsiveness of the UFS-QOL to therapies for leiomyomata.
This article has been cited by other articles:
|
|
 |
|
  E. D. Levens, C. Potlog-Nahari, A. Y. Armstrong, R. Wesley, A. Premkumar, D. L. Blithe, W. Blocker, and L. K. Nieman CDB-2914 for Uterine Leiomyomata Treatment: A Randomized Controlled Trial Obstet. Gynecol., May 1, 2008; 111(5): 1129 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tropeano, S. Amoroso, and G. Scambia Non-surgical management of uterine fibroids Hum. Reprod. Update, May 1, 2008; 14(3): 259 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Verma, D. Bergin, C. F. Gonsalves, D. G. Mitchell, A. S. Lev-Toaff, and L. Parker Submucosal Fibroids Becoming Endocavitary Following Uterine Artery Embolization: Risk Assessment by MRI Am. J. Roentgenol., May 1, 2008; 190(5): 1220 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. K. Hehenkamp, N. A. Volkers, E. Birnie, J. A. Reekers, and W. M. Ankum Symptomatic Uterine Fibroids: Treatment with Uterine Artery Embolization or Hysterectomy--Results from the Randomized Clinical Embolisation versus Hysterectomy (EMMY) Trial Radiology, March 1, 2008; 246(3): 823 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Goodwin, J. B. Spies, R. Worthington-Kirsch, E. Peterson, G. Pron, S. Li, E. R. Myers, and for the Fibroid Registry for Outcomes Data (FIBROI Uterine Artery Embolization for Treatment of Leiomyomata: Long-Term Outcomes From the FIBROID Registry Obstet. Gynecol., January 1, 2008; 111(1): 22 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Spies Sustained Relief of Leiomyoma Symptoms by Using Focused Ultrasound Surgery Obstet. Gynecol., December 1, 2007; 110(6): 1427 - 1428. [Full Text] [PDF]
|
|
|
|
|
|
C. Recaldini, G. Carrafiello, D. Lagana, S. Cuffari, V. Bergamini, F. Ghezzi, and C. Fugazzola Percutaneous Sonographically Guided Radiofrequency Ablation of Medium-Sized Fibroids: Feasibility Study Am. J. Roentgenol., December 1, 2007; 189(6): 1303 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Stewart, B. Gostout, J. Rabinovici, H. S. Kim, L. Regan, C. M. C. Tempany, and for the Magnetic Resonance Imaging Guided Focused Sustained Relief of Leiomyoma Symptoms by Using Focused Ultrasound Surgery Obstet. Gynecol., August 1, 2007; 110(2): 279 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Fennessy, C. M. Tempany, N. J. McDannold, M. J. So, G. Hesley, B. Gostout, H. S. Kim, G. A. Holland, D. A. Sarti, K. Hynynen, et al. Uterine Leiomyomas: MR Imaging-guided Focused Ultrasound Surgery--Results of Different Treatment Protocols Radiology, June 1, 2007; 243(3): 885 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fiscella, S. H. Eisinger, S. Meldrum, C. Feng, S. G. Fisher, and D. S. Guzick Effect of Mifepristone for Symptomatic Leiomyomata on Quality of Life and Uterine Size: A Randomized Controlled Trial Obstet. Gynecol., December 1, 2006; 108(6): 1381 - 1387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Scheurig, A. Gauruder-Burmester, C. Kluner, R. Kurzeja, A. Lembcke, E. Zimmermann, B. Hamm, and T. Kroencke Uterine artery embolization for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results Hum. Reprod., December 1, 2006; 21(12): 3270 - 3277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. C. Smart, J. T. Hindley, L. Regan, and W. G. Gedroyc Gonadotrophin-Releasing Hormone and Magnetic-Resonance-Guided Ultrasound Surgery for Uterine Leiomyomata. Obstet. Gynecol., July 1, 2006; 108(1): 49 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. McDannold, C. M. Tempany, F. M. Fennessy, M. J. So, F. J. Rybicki, E. A. Stewart, F. A. Jolesz, and K. Hynynen Uterine Leiomyomas: MR Imaging-based Thermometry and Thermal Dosimetry during Focused Ultrasound Thermal Ablation. Radiology, July 1, 2006; 240(1): 263 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Katsumori, T. Kasahara, and K. Akazawa Long-term outcomes of uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids. Am. J. Roentgenol., March 1, 2006; 186(3): 848 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Bucek, S. Puchner, and J. Lammer Mid- and Long-Term Quality-of-Life Assessment in Patients Undergoing Uterine Fibroid Embolization. Am. J. Roentgenol., March 1, 2006; 186(3): 877 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Spies, E. R. Myers, R. Worthington-Kirsch, J. Mulgund, S. Goodwin, M. Mauro, and for the FIBROID Registry Investigators The FIBROID Registry: Symptom and Quality-of-Life Status 1 Year After Therapy Obstet. Gynecol., December 1, 2005; 106(6): 1309 - 1318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Myers, S. Goodwin, W. Landow, M. Mauro, E. Peterson, G. Pron, J. B. Spies, R. Worthington-Kirsch, and for the FIBROID Investigators Prospective Data Collection of a New Procedure by a Specialty Society: The FIBROID Registry Obstet. Gynecol., July 1, 2005; 106(1): 44 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hindley, W. M. Gedroyc, L. Regan, E. Stewart, C. Tempany, K. Hynnen, N. Macdanold, Y. Inbar, Y. Itzchak, J. Rabinovici, et al. MRI Guidance of Focused Ultrasound Therapy of Uterine Fibroids: Early Results Am. J. Roentgenol., December 1, 2004; 183(6): 1713 - 1719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Myers Uterine Artery Embolization: What More Do We Need to Know? Obstet. Gynecol., November 1, 2002; 100(5): 847 - 848. [Full Text] [PDF]
|
|
|
|
|
|
E. R. Myers, M. D. Barber, T. Gustilo-Ashby, G. Couchman, D. B. Matchar, and D. C. McCrory Management of Uterine Leiomyomata: What Do We Really Know? Obstet. Gynecol., July 1, 2002; 100(1): 8 - 17. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
